...
首页> 外文期刊>International Journal of Pharmaceutics >Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
【24h】

Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.

机译:用于脂质纳米颗粒(SLN和NLC)配制的多羟基表面活性剂:对尺寸,物理稳定性和颗粒基质结构的影响。

获取原文
获取原文并翻译 | 示例

摘要

The two polyhydroxy surfactants polyglycerol 6-distearate (Plurol((R))Stearique WL1009 - (PS)) and caprylyl/capryl glucoside (Plantacare((R)) 810 - (PL)) are a class of PEG-free stabilizers, made from renewable resources. They were investigated for stabilization of aqueous solid lipid nanoparticle (SLN) and nanostructured lipid carrier (NLC) dispersions. Production was performed by high pressure homogenization, analysis by photon correlation spectroscopy (PCS), laser diffraction (LD), zeta potential measurements and differential scanning calorimetry (DSC). Particles were made from Cutina CP as solid lipid only (SLN) and its blends with Miglyol 812 (NLC, the blends containing increasing amounts of oil from 20% to 60%). The obtained particle sizes were identical for both surfactants, about 200 nm with polydispersity indices below 0.20 (PCS), and unimodal size distribution (LD). All dispersions with both surfactants were physically stable for 3 months at room temperature, but Plantacare (PL) showing a superior stability. The melting behaviour and crystallinity of bulk lipids/lipid blends were compared to the nanoparticles. Both were lower for the nanoparticles. The crystallinity of dispersions stabilized with PS was higher, the zeta potential decreased with storage time associated with this higher crystallinity, and leading to a few, but negligible larger particles. The lower crystallinity particles stabilized with PL remained unchanged in zeta potential (about -50 mV) and in size. These data show that surfactants have a distinct influence on the particle matrix structure (and related stability and drug loading), to which too little attention was given by now. Despite being from the same surfactant class, the differences on the structure are pronounced. They are attributed to the hydrophobic-lipophilic tail structure with one-point anchoring in the interface (PL), and the loop conformation of PS with two hydrophobic anchor points, i.e. their molecular structure and its interaction with the matrix surface and matrix bulk. Analysis of the effects of the surfactants on the particle matrix structure could potentially be used to further optimization of stability, drug loading and may be drug release.
机译:两种多羟基表面活性剂聚硬脂酸6-甘油酯(Plurol?来自可再生资源。研究了它们用于稳定固体脂质纳米颗粒(SLN)和纳米结构脂质载体(NLC)分散体的稳定性。通过高压均质,光子相关光谱法(PCS),激光衍射(LD),ζ电位测量和差示扫描量热法(DSC)进行生产。由Cutina CP仅作为固体脂质(SLN)制成颗粒,并将其与Miglyol 812(NLC,共混物,其油含量从20%增至60%)混合。对于两种表面活性剂,获得的粒度均相同,约200 nm,多分散指数低于0.20(PCS),且单峰粒度分布(LD)。具有两种表面活性剂的所有分散体在室温下物理稳定3个月,但Plantacare(PL)显示出优异的稳定性。将本体脂质/脂质共混物的熔融行为和结晶度与纳米颗粒进行了比较。对于纳米颗粒,两者均较低。用PS稳定的分散体的结晶度较高,ζ电位随与此较高的结晶度相关的储存时间而降低,并导致少量但可忽略的较大颗粒。用PL稳定的较低结晶度的颗粒的Zeta电位(约-50 mV)和尺寸保持不变。这些数据表明,表面活性剂对颗粒基质结构(以及相关的稳定性和载药量)有明显的影响,目前对此的关注还很少。尽管来自相同的表面活性剂类别,但是结构上的差异是明显的。它们归因于在界面(PL)中具有一点锚定的疏水亲脂性尾部结构,以及具有两个疏水锚定点的PS的环构象,即它们的分子结构以及其与基质表面和基质体积的相互作用。分析表面活性剂对颗粒基质结构的影响可能会被用于进一步优化稳定性,载药量,并可能是药物释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号